5
↑5
↓0
—0
Evidence suggests Semaglutide mayincreaseHealth status.
5 studies (5 claims)
Emerging evidence
Study Claims
| Intervention | Direction | Endpoint | Type | Population | Dosage | Title |
|---|---|---|---|---|---|---|
| glucagon-like peptide-1 receptor agonists like semaglutide and tirzepatide | Increases - have promising effects | cardiovascular, renal, and liver health | Human | patients with obesity | — | Obesity as a Chronic Disease: A Narrative Review of Evolving Definitions, Management Strategies, and Cardiometabolic Prioritization. |